Berkeley Lights, Inc. announced Monash University, one of Australia's leading universities, has implemented the use of the Berkeley Lights Beacon® system and Opto® Plasma B Discovery workflow for antibody discovery research. The technology is housed in the Monash Antibody Technology Facility (MATF) where researchers not only from Monash University but elsewhere in Victoria, Australia and worldwide can utilize their services for antibody production, assay development, robotics, high throughput screening and antibody characterization. Some of the research advantages that Monash has experienced to date by using the Beacon Platform include: Accelerating the screening of primary B cells on the Berkeley Lights Beacon system for antibody discovery by weeks compared to the standard hybridoma process; Facilitating rapid screening of thousands of single plasma cells on the same day as cell isolation; and Identifying target-binding candidates in just one day, and sequencing of variable chains as well as generating recombinant antibodies in 2–4 weeks.